CERE-110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CERE-110, covering 2020-12-21 to 2020-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]